Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02756442
Other study ID # 2015-A01796-43
Secondary ID 2015-41
Status Active, not recruiting
Phase N/A
First received April 27, 2016
Last updated April 27, 2016
Start date April 2016
Est. completion date April 2019

Study information

Verified date April 2016
Source Assistance Publique Hopitaux De Marseille
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Introduction:

The pregnancy brings about physiological and hormonal modifications which cause sleep disorder. The sleeplessness, snoring and a bad sleepquality are frequent during the pregnancy. Also a limited breathing airflow happens very often during the pregnancy. The limited airflow causes micro-awakenings that enter in the frame of the high resistances airways syndrome. To our knowledge there is no study about the outcome of micro-awakenings at pregnant women.

Objectives:

To compare the prevalence of the high resistances airways syndrome (RERA) in pregnant woman with or without gestational diabetes

Methods :

It is a monocentrical prospective study at pregnant women after the 30th amenorrhea week who consul the gynecologie and obstetrics department of the CHU NORD in Marseille. We are going to compare the breathing disorder during sleep of a control group with a group of women with gestational diabetes. A polysomnograph will be run at the included patients' home.

Expected results :

The physiological and hormonal modifications during the pregnancy could favor nocturnal sleep events (snoring, SAHOS and RERA) and its complications as gravidic HPN And gestational diabetes cause maternal and fœtal and morbidity and mortality. We put the hypothesis that limited airflow in association with micro-awakenings in the RERA have a negative impact on the glucose metabolism and favor the gestational diabetes.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date April 2019
Est. primary completion date April 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

Pregnant woman in the 3rd quarter of pregnancy (24 to 32 weeks amennorhea).

- Presenting a gestational diabetes ou not (=controle group)

- Written and signed consent.

Exclusion Criteria:

- Twin pregnancy

- High blood pressure before pregnancy

- Diabetes diagnosed before pregnancy

- Left ventricular ejection fraction below 40%

- Alcohol consumption (more than 7 glaces/day), drugs of type hypnotic, sedative, opioids

- History of gestational diabetes or glucose intolerance

- Severe cronical respiratory impairment (severe asthma)

- Creatinine clairance below 60 mL/min

Study Design

Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
Respiratory disorder assessment during sleep


Locations

Country Name City State
France Assistance Publique Hopitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Respiratory Disturbance Index Compare the respiratory disorder during sleep for pregnant women betwwen 2 groups with and without gestational diabetes based on RDI (Respiratory Disturbance Index) 4 month No
Secondary Air flow debit associated to micro awaking during sleep To assess the resistance airways syndrome 4 month No